CDK4 and neoplasm: Therefore, inhibition of CDK4/6 kinases leads to an increase in PD-L1 protein levels by hindering cyclin D-CDK4-mediated SPOP, resulting in a decrease in the number of tumor-infiltrating lymphocytes (TILs) in tumors [123].